Congratulations to Dr. Janardhan on receiving the 2019 SVIN (Society of Vascular and Interventional Neurology) Award. This award recognizes its members for their substantial service, outstanding contribution, training, mentoring, and innovative leadership in the field of vascular and interventional neurology. Dr. Janardhan will receive this award at the SVIN Annual Meeting held in Atlanta, Georgia, November 20-23, 2019.

Dr. Janardhan is the co-founder and Chief Medical Officer of Insera Therapeutics, Inc. He is the co-inventor of Insera's portfolio of medical devices for the prevention and treatment of acute ischemic stroke (aka brain attacks), hemorrhagic stroke (aka brain bleeds), brain aneurysms, and peripheral vascular disease. He currently holds 65+ issued and allowed U.S. and worldwide patents with 15+ patents pending in the U.S. and worldwide.

Dr. Janardhan is a trained stroke and intervational neurologist. In the last 8 years, he developed the Texas Stroke Institute (part of Hospital Corporation of America), the first health-system to have a multi-hub and spoke system of brain attack care in the US. His efforts have improved access to cutting-edge therapies within the "stroke belt" and dramatically improved brain attack treatment rates from 1.7% to 26% resulting in one of the largest regional brain attack networks in the country with over 160+ free standing ED's and hospitals in North Texas and Oklahoma.

During this time, he led the initiative to help certify or re-certify nine of eleven hospitals within the Texas Stroke Institute to successfully maintain The Joint Commission primary stoke center certification. He also led the initiative to help develop three hospitals into comprehensive stroke programs based on the brain-attack coalition guidelines.

Prior to moving to Texas, Dr. Janardhan served as the Director of Stroke and Interventional Neurology at the University of Minnesota Medical Center and helped launch the Minnesota Stroke Initiative. He completed his Vascular & Critical Care Neurology Fellowship at Massachusetts General Hospital (Harvard Medical School) and his Interventional Neuroradiology Fellowship at the University Hospitals of Cornell and Columbia.

Dr. Janardhan is a founding member of the Society of Vascular and Interventional Neurology and currently serves on their Board of Directors. He helped launched the SVIN Stroke Center Workshop, which has now become an internationally recognized conference regarding organizing stroke systems of care and stroke infrastructure. He is also part of the leadership committee for SVIN's Missions 2020 goal of increasing access to stroke treatments worldwide.

Please help us congratulate Dr. Janardhan on receiving this outstanding award!